1. Metabolic Enzyme/Protease NF-κB Immunology/Inflammation Anti-infection
  2. HIF/HIF Prolyl-Hydroxylase Reactive Oxygen Species (ROS) Bacterial Influenza Virus Endogenous Metabolite
  3. Chlorogenic acid

クロロゲン酸  (Synonyms: Chlorogenic acid; 3-O-Caffeoylquinic acid; Heriguard; NSC-407296)

製品番号: HY-N0055 純度: 99.53%
COA 取扱説明書 Technical Support

Chlorogenic acid is a major phenolic compound in Lonicera japonica Thunb. It is an orally active antioxidant activity, antibacterial, hepatoprotective, cardioprotective, anti-inflammatory, antipyretic, neuroprotective, anti-obesity, antiviral, anti-microbial, anti-hypertension compound.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 327-97-9

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 33 在庫あり
Solution
10 mM * 1 mL in DMSO USD 33 在庫あり
Solid
100 mg $30 在庫あり
500 mg $60 在庫あり
1 g $84 在庫あり
5 g $190 在庫あり
10 g   お問い合わせ  
50 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 30 publication(s) in Google Scholar

Other Forms of Chlorogenic acid:

Top Publications Citing Use of Products
Bio/Physico-chemical Assay
Gel Electrophoresis
WB
Histological Imaging/Staining
IHC

    Chlorogenic acid purchased from MedChemExpress. Usage Cited in: Int J Med Microbiol. 2023 Mar;313(2):151576.

    Chlorogenic acid (CGA; 50 μg/mL; 1 h) inhibits the Klebsiella pneumoniae (Kp)-induced increase in p38 expression levels as well as increases in p-p38/p-38 and p-MK2/MK2 levels, in RLE6TN cells.

    Chlorogenic acid purchased from MedChemExpress. Usage Cited in: J Agric Food Chem. 2020 Jul 29;68(30):8050-8056.  [Abstract]

    Dose-dependent inhibition of AtMS1 activity by Chlorogenic acid (10, 20, 50, 100, 200 μM).

    Chlorogenic acid purchased from MedChemExpress. Usage Cited in: J Agric Food Chem. 2020 Jul 29;68(30):8050-8056.  [Abstract]

    Gel-based competitive labeling of recombinant AtMS1 with various small molecules as competitors. Chlorogenic acid (100 μM) significantly reduce probe labeling.

    Chlorogenic acid purchased from MedChemExpress. Usage Cited in: J Agric Food Chem. 2020 Jul 29;68(30):8050-8056.  [Abstract]

    Dose-dependent inhibition of G1-yne labeling of AtMS1 by Chlorogenic acid (10, 20, 50, 100, 200 μM)

    Chlorogenic acid purchased from MedChemExpress. Usage Cited in: Life Sci. 2020 Aug 1;254:117590.  [Abstract]

    Hematoxylin and eosin (H&E) stained micrographs of histological features of rat bladder sections. There was a significant amelioration of injury and inflammation in the IC + CGA group after Chlorogenic acid (CGA) (100 mg/kg; i.p.) treatment.

    Chlorogenic acid purchased from MedChemExpress. Usage Cited in: Life Sci. 2020 Aug 1;254:117590.  [Abstract]

    IHC assays were used to detect the expression of the inflammatory markers IL-6, IL-1β, TNF-α, and NF-κB in bladder tissues was decreased after Chlorogenic acid (CGA) (100 mg/kg; i.p.) treatment.

    Chlorogenic acid purchased from MedChemExpress. Usage Cited in: Life Sci. 2020 Aug 1;254:117590.  [Abstract]

    Western blot results show the expression levels of IL6, IL-1β, and TNF-α was decreased after Chlorogenic acid (CGA) (100 mg/kg; i.p.) treatment.

    HIF/HIF Prolyl-Hydroxylase アイソフォーム固有の製品をすべて表示:

    Endogenous Metabolite アイソフォーム固有の製品をすべて表示:

    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Chlorogenic acid is a major phenolic compound in Lonicera japonica Thunb. It is an orally active antioxidant activity, antibacterial, hepatoprotective, cardioprotective, anti-inflammatory, antipyretic, neuroprotective, anti-obesity, antiviral, anti-microbial, anti-hypertension compound[1][2][3].

    Cellular Effect
    Cell Line Type Value Description References
    BALB/3T3 IC50
    > 280 μM
    Compound: 14
    Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay
    Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay
    [PMID: 10096863]
    BMDC IC50
    > 50 μM
    Compound: 4
    Inhibition of LPS-induced IL-12 p40 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    Inhibition of LPS-induced IL-12 p40 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    [PMID: 25769817]
    BMDC IC50
    > 50 μM
    Compound: 4
    Inhibition of LPS-induced IL-6 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    Inhibition of LPS-induced IL-6 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    [PMID: 25769817]
    BMDC IC50
    > 50 μM
    Compound: 4
    Inhibition of LPS-induced TNF-alpha production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    Inhibition of LPS-induced TNF-alpha production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    [PMID: 25769817]
    BMDM IC50
    86 μM
    Compound: Chlorogenic acid
    Inhibition of M-CSF/RANKL-induced osteoclast differentiation in C57BL/6 mouse bone marrow macrophage assessed as reduction in multinucleated TRAP+ cells incubated for 6 days with fresh media replacement on day 3 and measured on day 6 by TRAP staining-based microscopic analysis
    Inhibition of M-CSF/RANKL-induced osteoclast differentiation in C57BL/6 mouse bone marrow macrophage assessed as reduction in multinucleated TRAP+ cells incubated for 6 days with fresh media replacement on day 3 and measured on day 6 by TRAP staining-based microscopic analysis
    [PMID: 31257875]
    HCT-116 IC50
    367 μM
    Compound: chlorogenic acid
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    [PMID: 12880319]
    HeLa IC50
    375 μM
    Compound: 26
    Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay
    Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay
    [PMID: 19520580]
    HeLa IC50
    > 200 μM
    Compound: Chlorogenic acid
    Inhibition of HDAC in human HeLa cells using Boc-Lys(AC)-AMC as substrate after 24 to 48 hrs by spectrofluorometry
    Inhibition of HDAC in human HeLa cells using Boc-Lys(AC)-AMC as substrate after 24 to 48 hrs by spectrofluorometry
    [PMID: 26996372]
    MT2 ED50
    > 497 μM
    Compound: chlorogenic acid
    Concentration that inhibits Human Immunodeficiency Virus Type 1 (HIV-1)-induced death of MT-2 cells
    Concentration that inhibits Human Immunodeficiency Virus Type 1 (HIV-1)-induced death of MT-2 cells
    [PMID: 9986720]
    SW480 IC50
    353 μM
    Compound: chlorogenic acid
    Cytotoxicity against human SW480 cells after 72 hrs by MTT assay
    Cytotoxicity against human SW480 cells after 72 hrs by MTT assay
    [PMID: 12880319]
    体外実験

    Chlorogenic acid (10 μM, 16 h) decreases HIF-1α protein levels in CoCl2 induced hypoxic A549 cells, but does not affect HIF-1α mRNA level[1].
    Chlorogenic acid (10 μM, 24 h) inhibits the hypoxia-induced HUVEC cell migration, invasion and tube formation of vascular endothelial cells[1].
    Chlorogenic acid (25, 50 μM, 24 h) inhibits cell proliferation of Huh7 cells, and reduces the number of invading and migrating cells[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    体内実験

    Chlorogenic acid (10 μM, s.c.) inhibits VEGF (200 ng/mL)-induced angiogenesis in C57BL/6J mice, by suppression of AKT activation (Matrigel plug assay)[1].
    Chlorogenic acid (10-100 mg/kg, p.o.) shows protective effects against experimental reflux esophagitis in rats[3].
    Chlorogenic acid (10 mg/kg, i.v.) prevents endotoxic mortality and induced TNF-α release of LPS-intoxicated C57BL/6 mice, and ameliorates acute liver injury of LPS/GalN-challenged mice[2].
    Chlorogenic acid (ip, 25-200 mg/kg) inhibits tumor growth in NOD/SCID mice inoculated with Huh7 or H446 cells[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Experimental reflux esophagitis (RE) in rats[1]
    Dosage: 10, 30, 100 mg/kg
    Administration: p.o.
    Result: Reduced esophageal lipid peroxidation (marker: MDA) and increased the reduced glutathione/oxidized glutathione ratio.
    Inhibited the increases in the serum level of TNF-α, and expressions of iNOS and COX-2 protein.
    Animal Model: LPS/GalN-challenged mice[2]
    Dosage: 10 mg/kg
    Administration: i.v.
    Result: Increased survival rates of LPS/GalN-intoxicated mice.
    Inhibited LPS/GalN-induced phosphorylation of NF-κB p65 or c-Jun, without affecting p-IRF3 levels in the liver lobules.
    臨床実験
    分子量

    354.31

    分子式

    C16H18O9

    CAS 番号
    Appearance

    Solid

    Color

    Off-white to light brown

    SMILES

    O=C([C@@]1(O)C[C@@H](OC(/C=C/C2=CC=C(O)C(O)=C2)=O)[C@H](O)[C@H](O)C1)O

    Structure Classification
    Initial Source
    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 100 mg/mL (282.24 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : 20 mg/mL (56.45 mM; ultrasonic and warming and heat to 60°C)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.8224 mL 14.1119 mL 28.2239 mL
    5 mM 0.5645 mL 2.8224 mL 5.6448 mL
    10 mM 0.2822 mL 1.4112 mL 2.8224 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (7.06 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (7.06 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
    純度とドキュメンテーション

    純度: 99.55%

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O / DMSO 1 mM 2.8224 mL 14.1119 mL 28.2239 mL 70.5597 mL
    5 mM 0.5645 mL 2.8224 mL 5.6448 mL 14.1119 mL
    10 mM 0.2822 mL 1.4112 mL 2.8224 mL 7.0560 mL
    15 mM 0.1882 mL 0.9408 mL 1.8816 mL 4.7040 mL
    20 mM 0.1411 mL 0.7056 mL 1.4112 mL 3.5280 mL
    25 mM 0.1129 mL 0.5645 mL 1.1290 mL 2.8224 mL
    30 mM 0.0941 mL 0.4704 mL 0.9408 mL 2.3520 mL
    40 mM 0.0706 mL 0.3528 mL 0.7056 mL 1.7640 mL
    50 mM 0.0564 mL 0.2822 mL 0.5645 mL 1.4112 mL
    DMSO 60 mM 0.0470 mL 0.2352 mL 0.4704 mL 1.1760 mL
    80 mM 0.0353 mL 0.1764 mL 0.3528 mL 0.8820 mL
    100 mM 0.0282 mL 0.1411 mL 0.2822 mL 0.7056 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Chlorogenic acid
    製品番号:
    HY-N0055
    数量:
    MCE 日本正規代理店: